• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2300149 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2023-08-02 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2101073 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-05-24 Hualan Biological Engineering Inc view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2200240 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-10-10 Guizhou Taibang Biological Products Co Ltd view
CYSB2400305 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-11-21 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2101160 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-08-18 Hualan Biological Engineering Inc view
CYSB2200138 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-06-07 Shanghai RAAS Blood Products Co Ltd view
CXSL2400234 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2024-04-16 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2200065 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-03-01 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2400260 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) Supplementary Application 2024-09-26 Shanxi Kangbao Biological Product Co Ltd view
CYSB2200109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-04-29 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2101142 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-08-10 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400096 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-04-25 Green Cross China Biological Products Co Ltd view
CXSL2200013 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(3.4) New Drug Application 2022-01-12 Guangdong Danxia Biology Pharmcy Co Ltd view
CYSB2400277 静注人免疫球蛋白 human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-10-23 Hualan Biological Engineering Inc view
CXSL2101366 静注人免疫球蛋白(10%) human immunoglobulin(PH4) Injection Biological Products(3.2) New Drug Application 2021-10-14 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2101111 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-07-13 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CYSB2400062 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products(原15) Supplementary Application 2024-03-05 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CYSB2101141 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2021-08-10 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400253 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view